Sci Pharmtech (TPE:4119) Total Current Liabilities: NT$1,036 Mil (As of Dec. 2025)


TPE:4119 Sci Pharmtech Inc TPE:4119
67 GF Score
Price NT$44.75
GF Value NT$96.74
Valuation Possible Value Trap
! 9 Warning Signs
View Full Analysis

What is Sci Pharmtech Total Current Liabilities?

Sci Pharmtech TPE:4119 -1.32% 67 Total Current Liabilities is NT$1,036 Mil as of Dec. 2025. GuruFocus rates TPE:4119 with a GF Score™ of 67/100 and a GF Value™ of NT$96.74 (Possible Value Trap). The stock has 9 warning signs investors should review.

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Sci Pharmtech's total current liabilities for the quarter that ended in Dec. 2025 was NT$1,036

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Sci Pharmtech Total Current Liabilities Related Terms

Sci Pharmtech Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Sci Pharmtech's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sci Pharmtech Total Current Liabilities Chart

Sci Pharmtech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 747.94 770.32 569.89 1,014.38 1,036.37

Sci Pharmtech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,014.38 923.23 1,016.54 960.51 1,036.37
TPE:4119
67GF Score
Sci Pharmtech Inc TPE:4119
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sci Pharmtech Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Sci Pharmtech's Total Current Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=298.864+684.331
+Other Current Liabilities+Current Deferred Liabilities
=53.176+0
=1,036

Sci Pharmtech's Total Current Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=298.864+684.331
+Other Current Liabilities+Current Deferred Liabilities
=53.176+0
=1,036

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of NT$1,036 Mil mean?
Sci Pharmtech (TPE:4119) has a Total Current Liabilities of NT$1,036 Mil as of Dec. 2025. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Sci Pharmtech and its competitors.
Is Sci Pharmtech's Total Current Liabilities too high?
Sci Pharmtech's current Total Current Liabilities is NT$1,036 Mil. Overall, Sci Pharmtech has a GF Score™ of 67/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sci Pharmtech's Total Current Liabilities compare to ZTS and UTHR?
Sci Pharmtech's Total Current Liabilities of NT$1,036 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for a Drug Manufacturers company?
A good Total Current Liabilities depends on the Drug Manufacturers industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Sci Pharmtech and its competitors. Sci Pharmtech's current Total Current Liabilities is NT$1,036 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sci Pharmtech stock overvalued right now?
Based on GuruFocus' analysis, Sci Pharmtech (TPE:4119) is currently considered Possible Value Trap. The stock's GF Value™ is NT$96.74, compared to a current price of NT$44.75 — trading 53.7% below its estimated fair value. The current Total Current Liabilities is NT$1,036 Mil. Sci Pharmtech's overall GF Score™ is 67/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Sci Pharmtech (TPE:4119), the current Total Current Liabilities is NT$1,036 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sci Pharmtech (TPE:4119) Overvalued in 2026?

Based on GuruFocus' analysis, Sci Pharmtech stock appears to be undervalued. The current stock price of NT$44.75 is trading 53.7% below its estimated GF Value™ of NT$96.74. GuruFocus considers Sci Pharmtech to be Possible Value Trap.

Key valuation signals for TPE:4119:

  • Total Current Liabilities: NT$1,036 Mil
  • GF Value™: NT$96.74 vs. price of NT$44.75 (53.7% below fair value)
  • GF Score™: 67/100 with 9 warning signs

No single metric tells the full story. See the TPE:4119 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sci Pharmtech Business Description

Address No.61, Lane 309, Haihu North Road, Luzhu District, Taoyuan, TWN, 33856
Sci Pharmtech Inc is engaged in the research and development, manufacture, and sales of active pharmaceutical ingredients, intermediates, and specialty chemicals. Geographically, the primary markets of the company are Italy, Germany, Japan, Taiwan, the United States, Switzerland, Spain, Belgium, Netherlands, and others.
67GF Score

Get the complete analysis for TPE:4119

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$44.75
Price
NT$96.74
GF Value